Bioanalytical Systems, Inc. financial reports, Bioanalytical Systems, Inc. annual revenue in 2024. When does Bioanalytical Systems, Inc. report revenue?
Bioanalytical Systems, Inc. total revenue, net income and dynamics of changes in US dollar today
The dynamics of Bioanalytical Systems, Inc. net revenue has changed by -1 868 000 $ over the last period. Bioanalytical Systems, Inc. net income is now -1 426 000 $. Net income, revenue and dynamics - the main financial indicators of Bioanalytical Systems, Inc.. Graph of the financial report of Bioanalytical Systems, Inc.. The financial report on the chart of Bioanalytical Systems, Inc. allows you to clearly see the dynamics of fixed assets. The value of the "total revenue of Bioanalytical Systems, Inc." on the chart is marked in yellow.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
31/12/2019
12 918 000 $
+49.77 % ↑
-1 426 000 $
-
30/09/2019
14 786 000 $
+64.54 % ↑
290 000 $
-
30/06/2019
10 861 000 $
+79.85 % ↑
-426 000 $
-
31/03/2019
9 344 000 $
+57.2 % ↑
-569 000 $
-1134.545 % ↓
31/12/2018
8 625 000 $
-
-85 000 $
-
30/09/2018
8 986 000 $
-
-200 000 $
-
30/06/2018
6 039 000 $
-
-75 000 $
-
31/03/2018
5 944 000 $
-
55 000 $
-
31/12/2017
5 377 000 $
-
26 000 $
-
30/09/2017
5 873 000 $
-
229 000 $
-
30/06/2017
5 836 000 $
-
221 000 $
-
Show:
to
Bioanalytical Systems, Inc. financial report charts
The dates of the latest financial statements of Bioanalytical Systems, Inc.: 30/06/2017, 30/09/2019, 31/12/2019. Dates and dates of financial statements are established by the laws of the country where the company operates. The current date of the financial report of Bioanalytical Systems, Inc. for today is 31/12/2019. Gross profit Bioanalytical Systems, Inc. is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Bioanalytical Systems, Inc. is 3 477 000 $
Bioanalytical Systems, Inc. quarterly report dates
Cost of revenue Bioanalytical Systems, Inc. is the total cost of producing and distributing of products and services of a company. Cost of revenue Bioanalytical Systems, Inc. is 9 441 000 $ Total revenue Bioanalytical Systems, Inc. refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Bioanalytical Systems, Inc. is 12 918 000 $ Operating revenue Bioanalytical Systems, Inc. is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides. Operating revenue Bioanalytical Systems, Inc. is 12 918 000 $
Operating income Bioanalytical Systems, Inc. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Bioanalytical Systems, Inc. is -1 020 000 $ Net income Bioanalytical Systems, Inc. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Bioanalytical Systems, Inc. is -1 426 000 $ Current assets Bioanalytical Systems, Inc. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Bioanalytical Systems, Inc. is 14 881 000 $
31/12/2019
30/09/2019
30/06/2019
31/03/2019
31/12/2018
30/09/2018
30/06/2018
31/03/2018
31/12/2017
30/09/2017
30/06/2017
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
3 477 000 $
4 811 000 $
3 129 000 $
2 561 000 $
2 419 000 $
3 170 000 $
1 625 000 $
1 740 000 $
1 581 000 $
1 864 000 $
1 931 000 $
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
9 441 000 $
9 975 000 $
7 732 000 $
6 783 000 $
6 206 000 $
5 816 000 $
4 414 000 $
4 204 000 $
3 796 000 $
4 009 000 $
3 905 000 $
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
12 918 000 $
14 786 000 $
10 861 000 $
9 344 000 $
8 625 000 $
8 986 000 $
6 039 000 $
5 944 000 $
5 377 000 $
5 873 000 $
5 836 000 $
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
12 918 000 $
14 786 000 $
10 861 000 $
9 344 000 $
8 625 000 $
8 986 000 $
6 039 000 $
5 944 000 $
5 377 000 $
5 873 000 $
5 836 000 $
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
-1 020 000 $
943 000 $
-250 000 $
-449 000 $
41 000 $
320 000 $
-32 000 $
110 000 $
11 000 $
292 000 $
337 000 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
-1 426 000 $
290 000 $
-426 000 $
-569 000 $
-85 000 $
-200 000 $
-75 000 $
55 000 $
26 000 $
229 000 $
221 000 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
162 000 $
230 000 $
128 000 $
145 000 $
124 000 $
166 000 $
142 000 $
149 000 $
139 000 $
125 000 $
127 000 $
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
13 938 000 $
13 843 000 $
11 111 000 $
9 793 000 $
8 584 000 $
8 666 000 $
6 071 000 $
1 630 000 $
1 570 000 $
1 572 000 $
1 594 000 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
14 881 000 $
12 421 000 $
10 818 000 $
7 682 000 $
7 737 000 $
8 061 000 $
6 578 000 $
5 550 000 $
5 568 000 $
5 306 000 $
5 049 000 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
60 918 000 $
41 980 000 $
38 644 000 $
31 783 000 $
30 903 000 $
31 268 000 $
21 553 000 $
20 400 000 $
20 530 000 $
20 417 000 $
20 395 000 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
511 000 $
606 000 $
506 000 $
520 000 $
723 000 $
773 000 $
1 458 000 $
672 000 $
933 000 $
434 000 $
919 000 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
27 618 000 $
17 481 000 $
16 028 000 $
12 200 000 $
11 813 000 $
11 801 000 $
8 987 000 $
360 000 $
356 000 $
352 000 $
607 000 $
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
-
672 000 $
933 000 $
434 000 $
919 000 $
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
50 548 000 $
31 270 000 $
28 310 000 $
21 493 000 $
20 155 000 $
20 384 000 $
12 982 000 $
4 411 000 $
4 496 000 $
4 579 000 $
4 916 000 $
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
82.98 %
74.49 %
73.26 %
67.62 %
65.22 %
65.19 %
60.23 %
21.62 %
21.90 %
22.43 %
24.10 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
10 335 000 $
10 675 000 $
10 299 000 $
10 255 000 $
10 713 000 $
10 849 000 $
8 536 000 $
8 618 000 $
8 528 000 $
8 467 000 $
8 227 000 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
1 454 000 $
210 000 $
656 000 $
4 000 $
907 000 $
1 277 000 $
1 368 000 $
82 000 $
760 000 $
-14 000 $
689 000 $
Last revenue report of Bioanalytical Systems, Inc. was 31/12/2019. According to last financial report total revenue in Bioanalytical Systems, Inc. was 12 918 000 US dollar and changed by +49.77% since last year. Net income in Bioanalytical Systems, Inc. was -1 426 000 $ in last quartal, net income changes to -1134.545%.
Total assets Bioanalytical Systems, Inc. refers to the total amount of assets owned by a person or entity. Total assets Bioanalytical Systems, Inc. is 60 918 000 $ Current cash Bioanalytical Systems, Inc. - the sum of all of the cash a company has on the date of report. Current cash Bioanalytical Systems, Inc. is 511 000 $ Current debt Bioanalytical Systems, Inc. is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital. Current debt Bioanalytical Systems, Inc. is 27 618 000 $
Bioanalytical Systems, Inc. stocks data
BASI stock price
Bioanalytical Systems, Inc. stock price today, BASI stock quote.
